Loading...

Psilocybin Stock Picks: An Investor's Shroom Trip Experience

0

Dec 08, 2020

Video Description

Psilocybin Stock Picks: An Investor's Shroom Trip Experience

0

Shrooms are suddenly everywhere — Oregon just voted to legalize magic mushrooms, and speculators quickly rushed to compare the psychedelic drug to cannabis, another psychoactive substance that's been pushing along the path to legalization. We spoke to a couple of members of the Dumb Money community about their shrooms experience, and some stock picks that are worth looking into considering the news.

Part of Dumb Money Series

Stocks Mentioned

Compass Pathways Plc logo

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States.It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. (From: StockAnalysis.com)

More...

MORE FROM DUMB MONEY

Move Left
Move Right

Join The Discussion

Be the first to Comment!

0 COMMENTS:

Leave your comment:
Move Left
Poster image for series: Dumb Money
Poster image for series: Trendline
Poster image for series: Cash Only
Poster image for series:  Bullish Podcast
Move Right

GET THE BEST OF BULLISH EACH WEEK.

MORE RECENT CONTENT